ArticleThe Journal of clinical investigation2019

Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer.

Mark P Labrecque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.